Paolo Tarantino

Paolo Tarantino is a notable cancer researcher affiliated with the Dana-Farber Cancer Institute and Harvard Medical School. He has been instrumental in advancing the understanding of novel cancer therapies, particularly focusing on antibody-drug conjugates (ADCs). His recent commentary highlights the promising potential of these therapies in improving survival rates and reducing recurrence in various cancers, signaling a new era in oncological treatment strategies.